Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ChemoCentryx Inc (NASDAQ:CCXI)

10.05
Delayed Data
As of Jul 21
 +0.03 / +0.30%
Today’s Change
3.95
Today|||52-Week Range
10.68
+35.81%
Year-to-Date
New Strong Buy Stocks for July 18th
Jul 18 / Zacks.com - Paid Partner Content
ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%
Jul 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close10.02
Today’s open10.12
Day’s range10.00 - 10.48
Volume612,506
Average volume (3 months)130,462
Market cap$484.1M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+20.37%
Earnings growth (this year)+19.38%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales28.79
Price/Book9.68

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...-0.11-0.71%
CTMXCytomX Therapeutics ...+0.19+1.42%
INOInovio Pharmaceutica...0.000.00%
PGNXProgenics Pharmaceut...0.000.00%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$11.9M
Annual profit (last year)-$40.0M
Net profit margin-334.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Thomas J. Schall
CFO, Secretary, CAO &
Principal Accounting Officer
Susan M. Kanaya
Corporate headquarters
Mountain View, California

Forecasts